Literature DB >> 18729183

Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries.

Shu-Chun Chuang1, Ghislaine Scelo, Jon M Tonita, Sharon Tamaro, Jon G Jonasson, Erich V Kliewer, Kari Hemminki, Elisabete Weiderpass, Eero Pukkala, Elizabeth Tracey, Soren Friis, Vera Pompe-Kirn, David H Brewster, Carmen Martos, Kee-Seng Chia, Paolo Boffetta, Paul Brennan, Mia Hashibe.   

Abstract

The objective of the study was to assess the risk of second primary cancers (SPCs) following a primary head and neck cancer (oral cavity, pharynx and larynx) and the risk of head and neck cancer as a SPC. The present investigation is a multicenter study from 13 population-based cancer registries. The study population involved 99,257 patients with a first primary head and neck cancer and contributed 489,855 person-years of follow-up. To assess the excess risk of SPCs following head and neck cancers, we calculated standardized incidence ratios (SIRs) by dividing the observed numbers of SPCs by the expected number of cancers calculated from accumulated person-years and the age-, sex- and calendar period-specific first primary cancer incidence rates in each of the cancer registries. During the observation period, there were 10,826 cases of SPCs after head and neck cancer. For all cancer sites combined, the SIR of SPCs was 1.86 (95% CI = 1.83-1.90) and the 20-year cumulative risk was 36%. Lung cancer contributed to the highest proportion of the SPCs with a 20-year cumulative risk of 13%. Excess second head and neck cancer risk was observed 10 years after diagnosis with lymphohaematopoietic cancers. The most common SPC following a first primary head and neck cancer was lung cancer. However, the highest excess of SPCs was in the head and neck region. These patterns were consistent with the notion that the pattern of cancer in survivors of head and neck cancer is dominated by the effect of tobacco smoking and alcohol drinking. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18729183     DOI: 10.1002/ijc.23798

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  70 in total

1.  Preinvasive Endobronchial Lesions: Lung Cancer Precursors and Risk Markers?

Authors:  Stephen Lam; Eva Szabo
Journal:  Am J Respir Crit Care Med       Date:  2015-12-15       Impact factor: 21.405

2.  Two for the price of one: Prevalence, demographics and treatment implications of multiple HPV mediated Head and Neck Cancers.

Authors:  William Strober; Sachie Shishido; Burton Wood; James S Lewis; Krystle Kuhs; Robert L Ferris; Daniel L Faden
Journal:  Oral Oncol       Date:  2019-11-22       Impact factor: 5.337

3.  Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer.

Authors:  Luc G T Morris; Andrew G Sikora; Snehal G Patel; Richard B Hayes; Ian Ganly
Journal:  J Clin Oncol       Date:  2010-12-28       Impact factor: 44.544

4.  Prevalence and Outcomes of Head and Neck versus Non-Head and Neck Second Primary Malignancies in Head and Neck Squamous Cell Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database.

Authors:  Andrew C Birkeland; Andrew J Rosko; Steven B Chinn; Mark E Prince; Gordon H Sun; Matthew E Spector
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2016-02-25       Impact factor: 1.538

5.  Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck.

Authors:  Nicolas Dornoff; Christian Weiß; Franz Rödel; Jens Wagenblast; Shahram Ghanaati; Nateghian Atefeh; Claus Rödel; Panagiotis Balermpas
Journal:  Strahlenther Onkol       Date:  2015-05-25       Impact factor: 3.621

6.  Guidelines for the Surgical Management of Oral Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Authors:  Young-Hoon Joo; Jae-Keun Cho; Bon Seok Koo; Minsu Kwon; Seong Keun Kwon; Soon Young Kwon; Min-Su Kim; Jeong Kyu Kim; Heejin Kim; Innchul Nam; Jong-Lyel Roh; Young Min Park; Il-Seok Park; Jung Je Park; Sung-Chan Shin; Soon-Hyun Ahn; Seongjun Won; Chang Hwan Ryu; Tae Mi Yoon; Giljoon Lee; Doh Young Lee; Myung-Chul Lee; Joon Kyoo Lee; Jin Choon Lee; Jae-Yol Lim; Jae Won Chang; Jeon Yeob Jang; Man Ki Chung; Yuh-Seok Jung; Jae-Gu Cho; Yoon Seok Choi; Jeong-Seok Choi; Guk Haeng Lee; Phil-Sang Chung
Journal:  Clin Exp Otorhinolaryngol       Date:  2019-02-02       Impact factor: 3.372

Review 7.  Molecular mechanisms of ethanol-associated oro-esophageal squamous cell carcinoma.

Authors:  Yao Liu; Hao Chen; Zheng Sun; Xiaoxin Chen
Journal:  Cancer Lett       Date:  2015-03-09       Impact factor: 8.679

8.  Molecular etiology of second primary tumors in contralateral tonsils of human papillomavirus-associated index tonsillar carcinomas.

Authors:  Andrew W Joseph; Takenori Ogawa; Justin A Bishop; Sofia Lyford-Pike; Xiaofei Chang; Timothy H Phelps; William H Westra; Sara I Pai
Journal:  Oral Oncol       Date:  2012-10-10       Impact factor: 5.337

9.  A Challenging Picture of Cancer-and Inflammation-Related Changes.

Authors:  Carsten Nieder; Rolf E Steen; Astrid Dalhaug
Journal:  Clin Med Oncol       Date:  2009-03-02

10.  Stereotactic radiosurgery may contribute to overall survival for patients with recurrent head and neck carcinoma.

Authors:  Koji Kawaguchi; Kengo Sato; Akihisa Horie; Susumu Iketani; Hiroyuki Yamada; Yasunori Nakatani; Junichi Sato; Yoshiki Hamada
Journal:  Radiat Oncol       Date:  2010-06-09       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.